Anti-STX4/ STX4A/ p35-2 monoclonal antibody

Anti-STX4/ STX4A/ p35-2 antibody for FACS & in-vivo assay

Target products collectionGo to STX4/STX4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1728-Ab-1/ GM-Tg-hg-MP1728-Ab-2Anti-Human STX4 monoclonal antibodyHuman
GM-Tg-rg-MP1728-Ab-1/ GM-Tg-rg-MP1728-Ab-2Anti-Rat STX4 monoclonal antibodyRat
GM-Tg-mg-MP1728-Ab-1/ GM-Tg-mg-MP1728-Ab-2Anti-Mouse STX4 monoclonal antibodyMouse
GM-Tg-cynog-MP1728-Ab-1/ GM-Tg-cynog-MP1728-Ab-2Anti-Cynomolgus/ Rhesus macaque STX4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1728-Ab-1/ GM-Tg-felg-MP1728-Ab-2Anti-Feline STX4 monoclonal antibodyFeline
GM-Tg-cang-MP1728-Ab-1/ GM-Tg-cang-MP1728-Ab-2Anti-Canine STX4 monoclonal antibodyCanine
GM-Tg-bovg-MP1728-Ab-1/ GM-Tg-bovg-MP1728-Ab-2Anti-Bovine STX4 monoclonal antibodyBovine
GM-Tg-equg-MP1728-Ab-1/ GM-Tg-equg-MP1728-Ab-2Anti-Equine STX4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1728-Ab-1/ GM-Tg-hg-MP1728-Ab-2; GM-Tg-rg-MP1728-Ab-1/ GM-Tg-rg-MP1728-Ab-2;
GM-Tg-mg-MP1728-Ab-1/ GM-Tg-mg-MP1728-Ab-2; GM-Tg-cynog-MP1728-Ab-1/ GM-Tg-cynog-MP1728-Ab-2;
GM-Tg-felg-MP1728-Ab-1/ GM-Tg-felg-MP1728-Ab-2; GM-Tg-cang-MP1728-Ab-1/ GM-Tg-cang-MP1728-Ab-2;
GM-Tg-bovg-MP1728-Ab-1/ GM-Tg-bovg-MP1728-Ab-2; GM-Tg-equg-MP1728-Ab-1/ GM-Tg-equg-MP1728-Ab-2
Products NameAnti-STX4 monoclonal antibody
Formatmab
Target NameSTX4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-STX4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species STX4/ STX4A/ p35-2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003845human STX4 Lentivirus plasmid
    ORF Viral VectorvGMLP003845human STX4 Lentivirus particle


    Target information

    Target IDGM-MP1728
    Target NameSTX4
    Gene ID6810,20909,81803,704880,489919,101090574,508675,100063460
    Gene Symbol and Synonymsp35-2,STX4,STX4A,Syn-4,Syn4,syntaxin-4
    Uniprot AccessionQ12846,Q08850,Q3SWZ3
    Uniprot Entry NameSTX4_HUMAN,STX4_RAT,STX4_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000103496
    Target ClassificationN/A

    The target: STX4, gene name: STX4, also named as STX4A, p35-2. Enables sphingomyelin phosphodiesterase activator activity. Involved in several processes, including cornified envelope assembly; positive regulation of immune effector process; and positive regulation of protein localization. Located in several cellular components, including basolateral plasma membrane; cytoplasmic vesicle; and lamellipodium. Part of SNARE complex. Is active in glutamatergic synapse and postsynapse. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.